FCP
TMO icon

Fidelis Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Fidelis Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.79M Sell
5,684
-408
-7% -$221K 0.2% 97
2025
Q4 		$3.53M Buy
6,092
+570
+10% +$322K 0.26% 81
2025
Q3 		$2.68M Buy
5,522
+1,448
+36% +$674K 0.21% 90
2025
Q2 		$1.83M Sell
4,074
-197
-5% -$82.4K 0.17% 108
2025
Q1 		$1.81M Buy
4,271
+628
+17% +$340K 0.19% 95
2024
Q4 		$2.16M Buy
3,643
+472
+15% +$260K 0.22% 85
2024
Q3 		$1.83M Buy
3,171
+25
+0.8% +$14.8K 0.22% 85
2024
Q2 		$1.85M Sell
3,146
-195
-6% -$112K 0.26% 73
2024
Q1 		$1.94M Buy
3,341
+202
+6% +$113K 0.29% 68
2023
Q4 		$1.67M Buy
3,139
+256
+9% +$124K 0.37% 58
2023
Q3 		$1.46M Buy
2,883
+257
+10% +$137K 0.5% 43
2023
Q2 		$1.37M Buy
2,626
+133
+5% +$71.8K 0.5% 50
2023
Q1 		$1.36M Buy
2,493
+1,158
+87% +$653K 0.58% 45
2022
Q4 		$729K Buy
+1,335
New +$707K 0.86% 32

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelis Capital Partners's TMO Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Thermo Fisher Scientific (TMO) stake by 6.7% in Q1 2026, selling an estimated $221K and leaving 5,684 shares worth $2.79M. The position accounts for 0.2% of the portfolio, ranked #97.

Fidelis Capital Partners first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.53M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fidelis Capital Partners held 5,684 shares of Thermo Fisher Scientific worth $2.79M as of Q1 2026.
  • Fidelis Capital Partners sold 408 Thermo Fisher Scientific shares in Q1 2026, an estimated $221K.
  • Thermo Fisher Scientific made up 0.2% of Fidelis Capital Partners's portfolio in Q1 2026, its #97 holding.
  • Fidelis Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Fidelis Capital Partners's Thermo Fisher Scientific position peaked at $3.53M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.